Acute Myeloid Leukemia with Minimal Differentiation — knowledge graph · CancerIndex

Knowledge graph · Cancer

Acute Myeloid Leukemia with Minimal Differentiation

hematologic malignancy

Identifier: CI-CAN-00007133
Entity page: /cancer/acute-myeloid-leukemia-with-minimal-differentiation ↗
Edges: 103

Neighbours: 15 drugs10 trials
Drawn: 25 of 25 neighbours (cap 60); table lists every fetched edge

Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.

Most connectedLung Non-Small Cell Carcinoma 3,147 Malignant Colorectal Neoplasm 1,866 ABL1 298 EGFR 276 Imatinib 450 Dasatinib 321

Neighbourhood

Radial view

Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.

Edges

Every edge, grouped by relationship

Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.

Relationship	Neighbour	Direction	Evidence level	Cancer context	Support	Claim	Source	Expand
Acute Myeloid Leukemia with Minimal Differentiation investigated in trials for …INVESTIGATED_IN_TRIALSderived15 of 36show all (up to 200)
→ investigated in trials for	Cytarabinesmall molecule 26 trials (0 active) · roll-up of the cancer and its descendants	—	—	Acute Myeloid Leukemia with Minimal Differentiation	26	Observed	clinicaltrials	graph →
→ investigated in trials for

Acute Myeloid Leukemia with Minimal Differentiation studied in …STUDIED_INderived10 of 67show all (up to 200)
→ studied in	NCT02071901Phase 2 · completed Eltrombopag Olamine in Improving Platelet Recovery in Older Patients With Acute Myeloid Leukemia Undergoing Chemotherapy · condition mapped ALIAS · 67 trials mapped (0 active)	—	—	Adult Acute Myeloid Leukemia with Minimal Differentiation	1	Observed	clinicaltrials	graph →
→ studied in	NCT00093470Phase 3 · completed Tipifarnib in Treating Patients With Acute Myeloid Leukemia in Remission · condition mapped ONTOLOGY_EXACT · 67 trials mapped (0 active)	—	—	Adult Acute Myeloid Leukemia with Minimal Differentiation	1	Observed	clinicaltrials	graph →
→ studied in	NCT00588991Phase 1 · completed Veliparib and Topotecan With or Without Carboplatin in Treating Patients With Relapsed or Refractory Acute Leukemia, High-Risk Myelodysplasia, or Aggressive Myeloproliferative Disorders · condition mapped ONTOLOGY_EXACT · 67 trials mapped (0 active)	—	—	Adult Acute Myeloid Leukemia with Minimal Differentiation	1	Observed	clinicaltrials	graph →
→ studied in	NCT02085408Phase 3 · completed Clofarabine or Daunorubicin Hydrochloride and Cytarabine Followed By Decitabine or Observation in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia · condition mapped ALIAS · 67 trials mapped (0 active)	—	—	Adult Acute Myeloid Leukemia with Minimal Differentiation	1	Observed	clinicaltrials	graph →
→ studied in	NCT01555268Phase 1 · completed Trebananib With or Without Low-Dose Cytarabine in Treating Patients With Acute Myeloid Leukemia · condition mapped ALIAS · 67 trials mapped (0 active)	—	—	Adult Acute Myeloid Leukemia with Minimal Differentiation	1	Observed	clinicaltrials	graph →
→ studied in	NCT01168219Phase 2 · completed Busulfan, Fludarabine Phosphate, and Anti-Thymocyte Globulin Followed By Donor Stem Cell Transplant and Azacitidine in Treating Patients With High-Risk Myelodysplastic Syndrome and Older Patients With Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 67 trials mapped (0 active)	—	—	Adult Acute Myeloid Leukemia with Minimal Differentiation	1	Observed	clinicaltrials	graph →
→ studied in	NCT01550185Phase 1 · terminated Eltrombopag Olamine in Treating Patients With Relapsed/Refractory Acute Myeloid Leukemia · condition mapped ALIAS · 67 trials mapped (0 active)	—	—	Adult Acute Myeloid Leukemia with Minimal Differentiation	1	Observed	clinicaltrials	graph →
→ studied in	NCT00352365Phase 2 · completed Lenalidomide in Treating Older Patients With Acute Myeloid Leukemia · condition mapped ALIAS · 67 trials mapped (0 active)	—	—	Adult Acute Myeloid Leukemia with Minimal Differentiation	1	Observed	clinicaltrials	graph →
→ studied in	NCT00369317Phase 3 · completed Combination Chemotherapy in Treating Young Patients With Down Syndrome and Acute Myeloid Leukemia or Myelodysplastic Syndromes · condition mapped ALIAS · 67 trials mapped (0 active)	—	—	Childhood Acute Myeloid Leukemia with Minimal Differentiation	1	Observed	clinicaltrials	graph →
→ studied in	NCT02105116NA · terminated AML Therapy With Irradiated Allogeneic Cells · condition mapped ALIAS · 67 trials mapped (0 active)	—	—	Adult Acute Myeloid Leukemia with Minimal Differentiation	1	Observed	clinicaltrials	graph →

Radial view

Every edge, grouped by relationship

Strongest chains